Mind Medicine: Psychedelics in Pharmacy

Course overview

0202-0000-26-086-L01-P Psychedelic therapies are rapidly moving from underground movements to clinical frontlines. With growing FDA interest, rescheduling efforts, and clinical trials on psilocybin, MDMA, and other agents, pharmacists are positioned to support safe, evidence-based integration into practice. Attend this session to explore the current state of psychedelic research, regulatory developments, and potential roles for pharmacists in future treatment models. Whether you're curious or cautious, this presentation offers a grounded look at how psychedelic therapies may shift the landscape of mental health and pharmacy.